{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:46:53Z","timestamp":1787957213553,"version":"build-2784847793"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T00:00:00Z","timestamp":1741910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s40121-025-01122-5","type":"journal-article","created":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T09:24:52Z","timestamp":1741944292000},"page":"881-888","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Impact of the COVID-19 Omicron Variant on Immunocompromised Patients: ICU Admissions and Increased Mortality"],"prefix":"10.1007","volume":"14","author":[{"given":"Jan","family":"Pander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4831-9507","authenticated-orcid":false,"given":"Fabian","family":"Termorshuizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan W.","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Beekman-Hendriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josien","family":"Lanfermeijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferishta","family":"Bakhshi-Raiez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave A.","family":"Dongelmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,14]]},"reference":[{"issue":"4","key":"1122_CR1","doi-asserted-by":"publisher","first-page":"2101196","DOI":"10.2807\/1560-7917.ES.2022.27.4.2101196","volume":"27","author":"D Eggink","year":"2022","unstructured":"Eggink D, Andeweg SP, Vennema H, van Maarseveen N, Vermaas K, Vlaemynck B, et al. Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022. Euro Surveill. 2022;27(4):2101196.","journal-title":"Euro Surveill"},{"key":"1122_CR2","unstructured":"RIVM. Variants of the coronavirus SARS-CoV-2. https:\/\/www.rivm.nl\/en\/coronavirus-covid-19\/current\/variants (Accessed 15 October 2024)."},{"key":"1122_CR3","unstructured":"WHO. Tracking SARS-CoV-2 variants. https:\/\/www.who.int\/activities\/tracking-SARS-CoV-2-variants (Accessed 15 October 2024)."},{"issue":"1","key":"1122_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13613-023-01238-2","volume":"14","author":"F Termorshuizen","year":"2024","unstructured":"Termorshuizen F, Dongelmans DA, Brinkman S, Bakhshi-Raiez F, Arbous MS, de Lange DW, et al. Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the consecutive stages of the COVID-19 pandemic in the Netherlands, an update. Ann Intensiv Care. 2024;14(1):11.","journal-title":"Ann Intensiv Care"},{"issue":"Suppl 1","key":"1122_CR5","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1093\/infdis\/jiad145","volume":"228","author":"R Paris","year":"2023","unstructured":"Paris R. SARS-CoV-2 infection and response to COVID-19 vaccination in patients with primary immunodeficiencies. J Infect Dis. 2023;228(Suppl 1):S24\u201333.","journal-title":"J Infect Dis"},{"key":"1122_CR6","unstructured":"RIVM. Vaccination of immunocompromised people. https:\/\/www.rivm.nl\/en\/coronavirus-covid-19\/vaccination\/immunocompromised (Accessed 15 Oct 2024)."},{"issue":"5","key":"1122_CR7","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1097\/01.CCM.0000215112.84523.F0","volume":"34","author":"JE Zimmerman","year":"2006","unstructured":"Zimmerman JE, Kramer AA, McNair DS, Malila FM. Acute physiology and chronic health evaluation (APACHE) IV: hospital mortality assessment for today\u2019s critically ill patients. Crit Care Med. 2006;34(5):1297\u2013310.","journal-title":"Crit Care Med"},{"key":"1122_CR8","unstructured":"Dutch-Federation-for-Nephrology. Kernboodschap RIVM 3e vaccinatie immuungecompromitteerden. https:\/\/www.nefro.nl\/nieuws\/kernboodschap-rivm-3e-vaccinatie-immuungecompromitteerden (Accessed 15 Oct 2024)."},{"key":"1122_CR9","doi-asserted-by":"publisher","first-page":"100747","DOI":"10.1016\/j.lanepe.2023.100747","volume":"35","author":"RA Evans","year":"2023","unstructured":"Evans RA, Dube S, Lu Y, Yates M, Arnetorp S, Barnes E, et al. Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study. Lancet Reg Health Eur. 2023;35:100747.","journal-title":"Lancet Reg Health Eur."},{"key":"1122_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.101965","volume":"59","author":"S Shoham","year":"2023","unstructured":"Shoham S, Batista C, Ben Amor Y, Ergonul O, Hassanain M, Hotez P, et al. Vaccines and therapeutics for immunocompromised patients with COVID-19. EClinicalMedicine. 2023;59: 101965.","journal-title":"EClinicalMedicine"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01122-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-025-01122-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-025-01122-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,12]],"date-time":"2025-04-12T21:03:28Z","timestamp":1744491808000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-025-01122-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,14]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1122"],"URL":"https:\/\/doi.org\/10.1007\/s40121-025-01122-5","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,14]]},"assertion":[{"value":"16 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Jan Pander, Wendy Beekman-Hendriks and Josien Lanfermeijer are employees of AstraZeneca BV. Fabian Termorshuizen, Dylan W. de Lange, Ferishta Bakhshi-Raiez and Dave A. Dongelmans have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This research complies with the WMA Helsinki declaration 2024. The Medical Ethics Review Committee of the Academic Medical Center approved of this study and waived the need for informed consent [reference number W21_091 # 21.102]. Permission to access and use the data was obtained according to the regulations of the NICE registry, and the used data were de-identified.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}